You are here

Merck

Pharma promises lawmakers, again and again, industry won’t cut corners with Covid-19 vaccines

Stat

Tue, 07/21/20 - 05:05 pm

Moderna Therapeutics

Merck taps contract research firm IRBM for peptides to hit back at pandemic virus

Fierce Biotech

Tue, 07/21/20 - 04:55 pm

How much will it cost? And 5 other questions Congress could push Covid-19 vaccine makers to answer

Stat

Mon, 07/20/20 - 12:08 pm

Moderna Therapeutics

NovoCure, Merck Team Up on Phase II Lung Cancer Trial

BioSpace

Wed, 07/15/20 - 11:16 pm

clinical trials

tumor treating fields

non-small cell lung cancer

Merck CEO Frazier says COVID-19 vaccine hype a 'grave disservice' to the public

Fierce Pharma

Tue, 07/14/20 - 12:15 pm

After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure

Endpoints

Mon, 07/13/20 - 11:09 am

Dewpoint Therapeutics

Moderna and Other Coronavirus Vaccine Developers to Testify in Congress July 21

Motley Fool

Sat, 07/11/20 - 12:08 pm

Moderna Therapeutics

Zymeworks inks new antibody licensing deal with Merck

Pharma Letter

Thu, 07/9/20 - 10:54 am

Merck teams up with cancer startup Foghorn in $425M deal

Fierce Biotech

Wed, 07/8/20 - 10:48 am

Foghorn Therapeutics

drug development

FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch

Endpoints

Wed, 07/8/20 - 10:43 am

complete response letter

hepatocellular carcinoma

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Pharmaforum

Tue, 07/7/20 - 10:40 am

Merck & Co’s Keytruda gets new colorectal cancer use after month-long FDA review

Pharmaforum

Tue, 06/30/20 - 10:53 am

colorectal cancer

Coalition of drugmakers to unveil $1B venture to pursue antibiotics

Beckers Hospital Review

Mon, 06/29/20 - 10:01 am

drug development

Boehringer Ingelheim

I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study

Fierce Pharma

Thu, 06/25/20 - 08:36 pm

immuno-oncology

checkpoint inhibitors

Bristol-Meyers Squibb

Merck treads on Sanofi, Regeneron's turf with Keytruda's latest skin cancer OK

Fierce Pharma

Wed, 06/24/20 - 11:41 pm

squamous cell carcinoma

Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases

BioSpace

Wed, 06/24/20 - 10:28 am

Yumanity Therapeutics

frontotemporal lobar dementia

Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies

BioSpace

Mon, 06/22/20 - 08:38 pm

clinical trials

pneumococcal disease

Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?

Fierce Pharma

Thu, 06/18/20 - 10:40 am

Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda

Endpoints

Wed, 06/17/20 - 10:48 am

Bristol-Myers Squibb

accelerated approvals

ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers

Fierce Pharma

Tue, 06/16/20 - 06:59 pm

Pages